Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience
Open Access
- 1 September 1990
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 120 (3), 672-676
- https://doi.org/10.1016/0002-8703(90)90026-t
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Fibrinogen and Risk of Cardiovascular DiseaseJAMA, 1987
- Lipids, diabetes, and coronary heart disease: Insights from the Framingham StudyAmerican Heart Journal, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980
- Increased Plasma Fibrinogen and Platelet-Aggregates in Type II HyperlipoproteinaemiaThrombosis and Haemostasis, 1979
- Diabetes and cardiovascular risk factors: the Framingham study.Circulation, 1979
- Diabetes, Blood Lipids, and the Role of Obesity in Coronary Heart Disease Risk for WomenAnnals of Internal Medicine, 1977
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974
- Fibrinogen AssayClinical Chemistry, 1967